Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Radiotherapy & Oncology Année : 2015

Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial

David Malka
  • Fonction : Auteur
Thierry Conroy
Beata Juzyna
  • Fonction : Auteur

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-02283068 , version 1 (10-09-2019)

Identifiants

Citer

Antonin Levy, David Azria, Jean-Pierre Pignon, Anne Delarochefordiere, Isabelle Martel-Lafay, et al.. Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial. Radiotherapy & Oncology, 2015, 114 (3), pp.415-416. ⟨10.1016/j.radonc.2015.02.008⟩. ⟨hal-02283068⟩
120 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More